All Stories

  1. Microanatomical organization of hepatic venous lymphatic system in humans
  2. Heterogeneity of metabolic adaptive capacity affects the prognosis among pancreatic ductal adenocarcinomas
  3. Differential diagnoses of gallbladder tumors using CT‐based deep learning
  4. CT-based deep learning enables early postoperative recurrence prediction for intrahepatic cholangiocarcinoma
  5. A Prospective Multicenter Phase II Study on the Feasibility and Efficacy of S-1 and Oxaliplatin Neoadjuvant Chemotherapy for Locally Advanced Rectal Cancer
  6. Short‐term outcomes of robotic‐assisted surgery following neoadjuvant chemotherapy for lower rectal cancer
  7. ASO Author Reflections: Reconsidering the Treatment Strategy for Resectable Pancreatic Cancer Using a Biomarker-Based Scoring System for Prediction of Early Recurrence
  8. ASO Visual Abstract: Development of a Biomarker-Based Scoring System Predicting Early Recurrence of Resectable Pancreatic Duct Adenocarcinoma
  9. Prediction of massive bleeding in pancreatic surgery based on preoperative patient characteristics using a decision tree
  10. Eukaryotic initiation factor 2 signaling behind neural invasion linked with lymphatic and vascular invasion in pancreatic cancer
  11. Development of a Biomarker-Based Scoring System Predicting Early Recurrence of Resectable Pancreatic Duct Adenocarcinoma
  12. Intraoperative Allogeneic Red Blood Cell Transfusion Negatively Influences Prognosis After Radical Surgery for Pancreatic Cancer
  13. Roles of the nervous system in pancreatic cancer
  14. Effective dissection for rectal cancer with lateral lymph node metastasis based on prognostic factors and recurrence type
  15. A case report of mucinous adenocarcinoma derived from intra-ampullary papillary-tubular neoplasm with a malignant course
  16. Essential updates 2018/2019: Current topics in the surgical treatment of pancreatic ductal adenocarcinoma
  17. Relationship Between Change Rate of Tacrolimus Clearance During Continuous Intravenous Infusion and Recipient Recovery at an Early Stage After Living Donor Liver Transplantation
  18. Iron overload as a risk factor for hepatic ischemia-reperfusion injury in liver transplantation: Potential role of ferroptosis
  19. Impact of Smoking Cessation in Donor Candidates for Living Donor Liver Transplantation
  20. Long-term Changes in Spleen Volume After Living Donor Liver Transplantation in Pediatric Recipients
  21. Castleman’s Lymphoma with Primary Occurrence in the Right Diaphragm
  22. Effect of sarcopenia on the outcomes after pancreaticoduodenectomy for distal cholangiocarcinoma
  23. Smoking cessation contributes to weight gain in patients with hepatobiliopancreatic malignancy
  24. Impact of the histological phenotype of extrahepatic bile duct carcinoma
  25. Microanatomical profiles on the lymphatic system in the human ampulla of Vater (immunohistochemistry and scanning electron microscopy)
  26. Living-Donor Liver Transplantation With the Use of a Left-Lobe Graft From a Donor With Anomalous Biliary Anatomy in Which B4 Joins the Right Anterior Sectional Duct: A Case Report
  27. Effect of age on the development of chemotherapy‑associated liver injury in colorectal cancer liver metastasis
  28. Combination therapy with gemcitabine and nab-paclitaxel for locally advanced unresectable pancreatic cancer
  29. Prognostic Impact of CD163+ Macrophages in Tumor Stroma and CD8+ T-Cells in Cancer Cell Nests in Invasive Extrahepatic Bile Duct Cancer
  30. Perihilar Cholangiocarcinoma with Constitutional Indocyanine Green Defect Treated by Right Hemihepatectomy Extending to Segment 1
  31. Living donor liver transplantation in a pediatric patient with preexisting yolk sac tumor
  32. Locally Advanced Gallbladder Cancer Treated with Chemotherapy and Subsequent Curative Resection
  33. Impact of the serum ferritin concentration in liver transplantation
  34. Examinations of ascites from prophylactic drains can predict intra-abdominal infections after living donor liver transplantation
  35. Successful rescue of disseminated varicella infection with multiple organ failure in a pediatric living donor liver transplant recipient: a case report and literature review
  36. Perioperative blood transfusion as a poor prognostic factor after aggressive surgical resection for hilar cholangiocarcinoma
  37. The impact of rituximab in ABO-incompatible pediatric living donor liver transplantation: The experience of a single center
  38. Perioperative Blood Transfusion as a Poor Prognostic Factor After Aggressive Surgical Resection for Hilar Cholangiocarcinoma
  39. Selection of living donor liver grafts for patients weighing 6kg or less
  40. Iron Overload After Pediatric Liver Transplantation: A Case Report
  41. Successful Treatment of Severe Anastomotic Stricture of a Choledochojejunostomy After Living Donor Liver Transplantation With Transhepatic Cholangioscopy-Guided Balloon Dilatation
  42. Maternal grafts protect daughter recipients from acute cellular rejection after pediatric living donor liver transplantation for biliary atresia
  43. Impact of post-transplant flow cytometric panel-reactive antibodies on late-onset hepatic venous outflow obstruction following pediatric living donor liver transplantation
  44. Protocol liver biopsy is the only examination that can detect mid-term graft fibrosis after pediatric liver transplantation
  45. Risk factors and treatments for hepatic arterial complications in pediatric living donor liver transplantation
  46. Decreased portal vein flow during Kawasaki disease in a liver transplant patient
  47. Evaluation of the Usefulness of the Indocyanine Green Clearance Test for Chemotherapy-Associated Liver Injury in Patients with Colorectal Cancer Liver Metastasis
  48. Effect of Repeat Kasai Hepatic Portoenterostomy on Pediatric Live-Donor Liver Graft for Biliary Atresia
  49. Impact of endotoxin measured by an endotoxin activity assay during liver transplantation
  50. Development of nonalcoholic fatty liver disease after pancreaticoduodenectomy
  51. A Comparison of Open Surgery and Endovascular Intervention for Hepatic Artery Complications After Pediatric Liver Transplantation
  52. Impact of localized ascites after pediatric living donor liver transplantation: report of three cases
  53. The efficacy of measurement of the serum beta-d glucan in the patients with biliary atresia
  54. Liver graft volumetric changes after living donor liver transplantation with segment 2 graft for small infants
  55. Use of 3-Dimensional Computed Hepatic Venous Visualization for Graft Outflow Venoplasty in Adult Left Living-Donor Liver Transplant
  56. Impact of Posttransplant Portosystemic Shunts on Liver Transplantation
  57. Role of Apheresis and Dialysis in Pediatric Living Donor Liver Transplantation: A Single Center Retrospective Study
  58. Prediction of Acute Cellular Rejection by Peripheral Blood Eosinophilia in Pediatric Living Donor Liver Transplantation
  59. Transumbilical portal venous catheterization: a useful adjunct in left lobe living donor liver transplantation
  60. Living donor liver transplantation from an asymptomatic mother who was a carrier for ornithine transcarbamylase deficiency
  61. Co-occurrence of Nonanastomotic Biliary Stricture and Acute Cellular Rejection in Liver Transplant
  62. Varicella Zoster Virus Disease After Pediatric Living Donor Liver Transplantation: Is It Serious?
  63. Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Associated With Potential Antibody-Mediated Rejection After Pediatric Living Donor Liver Transplantation: A Case Report
  64. Liver transplantation for a pediatric patient with hemophilia B
  65. Impact of enzyme activity assay on indication in liver transplantation for ornithine transcarbamylase deficiency
  66. The role of operative intervention in management of congenital extrahepatic portosystemic shunt
  67. Living Donor Liver Transplantation in Children With Cholestatic Liver Disease: A Single-Center Experience
  68. Hepatocellular Telomere Length in Biliary Atresia Measured by Q‐FISH
  69. Non-alcoholic steatohepatitis caused by malnutrition after pediatric liver transplantation
  70. Hepatic Arterial Buffer Response after Pediatric Living Donor Liver Transplantation: Report of a Case
  71. Pediatric liver retransplantation from living donors can be considered as a therapeutic option for patients with irreversible living donor graft failure
  72. Endovascular interventions for hepatic artery complications immediately after pediatric liver transplantation
  73. Impact of hepatic clearance of endotoxin using endotoxin activity assay
  74. Living donor liver transplantation for ornithine transcarbamylase deficiency
  75. Pediatric living donor liver transplantation for biliary atresia with hepatopulmonary syndrome: the gift of a second wind
  76. Indication of liver transplantation for jaundice-free biliary atresia with portal hypertension
  77. Liver allograft with hemangioma in pediatric living donor liver transplantation
  78. Interventional radiology for hepatic artery complications soon after living donor liver transplantation in a neonate
  79. Hepatic artery reconstruction with the jejunal artery of the Roux‐en‐Y limb in pediatric living donor liver re‐transplantation
  80. Living-Donor Liver Transplantation in 126 Patients with Biliary Atresia: Single-Center Experience
  81. Management of Intra-Abdominal Drain After Living Donor Liver Transplantation
  82. Living Donor Liver Transplantation for Neonates Using Segment 2 Monosubsegment Graft
  83. Bowel perforation after pediatric living donor liver transplantation
  84. Double-balloon enteroscopy for bilioenteric anastomotic stricture after pediatric living donor liver transplantation
  85. Strategy to prevent recurrent portal vein stenosis following interventional radiology in pediatric liver transplantation
  86. An efficacy of surgical treatment for congenital extrahepatic portosystemic shunt: Report of two cases
  87. Living Donor Liver Transplantation for Congenital Absence of the Portal Vein